Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 19
2017 41
2018 58
2019 49
2020 37
2021 27
2022 13
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Photobiomodulation therapy (red/NIR LEDs) reduced the length of stay in intensive care unit and improved muscle function: A randomized, triple-blind, and sham-controlled trial.
Neto RPM, Espósito LMB, da Rocha FC, Filho AAS, Silva JHG, de Sousa Santos EC, Sousa BLSC, Dos Santos Gonçalves KRR, Garcia-Araujo AS, Hamblin MR, Ferraresi C. Neto RPM, et al. J Biophotonics. 2024 May;17(5):e202300501. doi: 10.1002/jbio.202300501. Epub 2024 Jan 23. J Biophotonics. 2024. PMID: 38262071 Clinical Trial.
Transcranial photobiomodulation mitigates learning and memory impairments induced by hindlimb unloading in a mouse model of microgravity exposure by suppression of oxidative stress and neuroinflammation signaling pathways.
Kazmi S, Farajdokht F, Meynaghizadeh-Zargar R, Sadigh-Eteghad S, Pasokh A, Farzipour M, Farazi N, Hamblin MR, Mahmoudi J. Kazmi S, et al. Brain Res. 2023 Dec 15;1821:148583. doi: 10.1016/j.brainres.2023.148583. Epub 2023 Sep 17. Brain Res. 2023. PMID: 37717889
Dose and time-response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: A randomized, crossover, double-blind, sham-controlled trial.
Scontri CMCB, de Castro Magalhães F, Damiani APM, Hamblin MR, Zamunér AR, Ferraresi C. Scontri CMCB, et al. J Biophotonics. 2023 Oct;16(10):e202300083. doi: 10.1002/jbio.202300083. Epub 2023 Jun 27. J Biophotonics. 2023. PMID: 37171054 Clinical Trial.
Receptor tyrosine kinase inhibitors in cancer.
Ebrahimi N, Fardi E, Ghaderi H, Palizdar S, Khorram R, Vafadar R, Ghanaatian M, Rezaei-Tazangi F, Baziyar P, Ahmadi A, Hamblin MR, Aref AR. Ebrahimi N, et al. Cell Mol Life Sci. 2023 Mar 22;80(4):104. doi: 10.1007/s00018-023-04729-4. Cell Mol Life Sci. 2023. PMID: 36947256 Free PMC article. Review.
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis.
Taheriazam A, Abad GGY, Hajimazdarany S, Imani MH, Ziaolhagh S, Zandieh MA, Bayanzadeh SD, Mirzaei S, Hamblin MR, Entezari M, Aref AR, Zarrabi A, Ertas YN, Ren J, Rajabi R, Paskeh MDA, Hashemi M, Hushmandi K. Taheriazam A, et al. J Control Release. 2023 Feb;354:503-522. doi: 10.1016/j.jconrel.2023.01.028. Epub 2023 Jan 19. J Control Release. 2023. PMID: 36641122 Review.
Effects of multiwavelength photobiomodulation for the treatment of traumatic soft tissue injuries associated with bone fractures: A double-blind, randomized controlled clinical trial.
Jana Neto FC, Martimbianco ALC, Mesquita-Ferrari RA, Bussadori SK, Alves GP, Almeida PVD, Delgado FG, Fonseca LR, Gama MZG, Jorge MD, Hamblin MR, Fernandes KPS. Jana Neto FC, et al. J Biophotonics. 2023 May;16(5):e202200299. doi: 10.1002/jbio.202200299. Epub 2023 Feb 3. J Biophotonics. 2023. PMID: 36640122 Clinical Trial.
213 results